MiRNAs regulate expression and function of extracellular matrix molecules

Matrix Biology

Volumn 32, Issue 2, 2013, Pages 74-85

  Rutnam, Zina Jeyapalan ^a,b   Wight, Thomas N ^c   Yang, Burton B ^a,b  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

3'UTR; Angiogenesis; Extracellular matrix; MicroRNA; Non coding RNA; Tumorigenesis

Indexed keywords

CADHERIN; COLLAGEN; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; GLYCOPROTEIN; GROWTH FACTOR; HERMES ANTIGEN; INTEGRIN; MATRIX METALLOPROTEINASE; MICRORNA; NEPHRONECTIN; PROTEOGLYCAN; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG; UVOMORULIN; VERSICAN;

CARTILAGE; CELL ADHESION; CELL MOTILITY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW;

CELL ADHESION; COLLAGEN; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; RNA, MESSENGER; VERSICANS;

EID: 84878242170     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2012.11.003     Document Type: Review

References (142)

1. Afify A., Purnell P., Nguyen L. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Exp. Mol. Pathol. 2009, 86:95-100.
2. Aguda B.D., Kim Y., Piper-Hunter M.G., Friedman A., Marsh C.B. MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19678-19683.
3. Akhtar N., Rasheed Z., Ramamurthy S., Anbazhagan A.N., Voss F.R., Haqqi T.M. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum. 2010, 62:1361-1371.
4. Altuvia Y., Landgraf P., Lithwick G., Elefant N., Pfeffer S., Aravin A., Brownstein M.J., Tuschl T., Margalit H. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 2005, 33:2697-2706.
5. Ameres S.L., Martinez J., Schroeder R. Molecular basis for target RNA recognition and cleavage by human RISC. Cell 2007, 130:101-112.
6. Augoff K., Das M., Bialkowska K., McCue B., Plow E.F., Sossey-Alaoui K. miR-31 is a broad regulator of beta1-integrin expression and function in cancer cells. Mol. Cancer Res. 2011, 9:1500-1508.
7. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
8. Baskerville S., Bartel D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005, 11:241-247.
9. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H., Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
10. Bloomston M., Frankel W.L., Petrocca F., Volinia S., Alder H., Hagan J.P., Liu C.G., Bhatt D., Taccioli C., Croce C.M. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297:1901-1908.
11. Brandenberger R., Schmidt A., Linton J., Wang D., Backus C., Denda S., Muller U., Reichardt L.F. Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin alpha8beta1 in the embryonic kidney. J. Cell Biol. 2001, 154:447-458.
12. Castoldi G., Di Gioia C.R., Bombardi C., Catalucci D., Corradi B., Gualazzi M.G., Leopizzi M., Mancini M., Zerbini G., Condorelli G., Stella A. MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J. Cell. Physiol. 2012, 227:850-856.
13. Chambers A.F., Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 1997, 89:1260-1270.
14. Chan C.K., Rolle M.W., Potter-Perigo S., Braun K.R., Van Biber B.P., Laflamme M.A., Murry C.E., Wight T.N. Differentiation of cardiomyocytes from human embryonic stem cells is accompanied by changes in the extracellular matrix production of versican and hyaluronan. J. Cell. Biochem. 2010, 111:585-596.
15. Chen Y., Stallings R.L. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 2007, 67:976-983.
16. Chen Z.L., Zhao X.H., Wang J.W., Li B.Z., Wang Z., Sun J., Tan F.W., Ding D.P., Xu X.H., Zhou F., Tan X.G., Hang J., Shi S.S., Feng X.L., He J. microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J. Biol. Chem. 2011, 286:10725-10734.
17. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
18. Cho W.C., Chow A.S., Au J.S. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol. 2011, 8:125-131.
19. Chow T.F., Youssef Y.M., Lianidou E., Romaschin A.D., Honey R.J., Stewart R., Pace K.T., Yousef G.M. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin. Biochem. 2010, 43:150-158.
20. Dalmay T., Edwards D.R. MicroRNAs and the hallmarks of cancer. Oncogene 2006, 25:6170-6175.
21. Dangi-Garimella S., Strouch M.J., Grippo P.J., Bentrem D.J., Munshi H.G. Collagen regulation of let-7 in pancreatic cancer involves TGF-beta1-mediated membrane type 1-matrix metalloproteinase expression. Oncogene 2011, 30:1002-1008.
22. Fang L., Deng Z., Shatseva T., Yang J., Peng C., Du W.W., Yee A.J., Ang L.C., He C., Shan S.W., Yang B.B. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 2011, 30:806-821.
23. Fang L., Du W.W., Yang W., Rutnam Z.J., Peng C., Li H., O'Malley Y.Q., Askeland R.W., Sugg S., Liu M., Mehta T., Deng Z., Yang B.B. MiR-93 Enhances Breast Cancer Tumorigenesis by Targeting LATS2. Cell Cycle 2012, 11(23). (Electronic publication ahead of print, PMID: 23111389, 2012 Oct 30).
24. Fang L., Du W.W., Yang X., Chen K., Ghanekar A., Levy G., Yang W., Lu W.Y., Xuan J.W., Gao Z.L., Xie F., He C., Deng Z., Yang B.B. Versican 3'-Untranslated Region (3'UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J. 2012, (Electronic publication ahead of print, PMID: 23180826, 2012 Dec 4).
25. Feng B., Chen S., McArthur K., Wu Y., Sen S., Ding Q., Feldman R.D., Chakrabarti S. miR-146a-mediated extracellular matrix protein production in chronic diabetes complications. Diabetes 2011, 60:2975-2984.
26. Foekens J.A., Sieuwerts A.M., Smid M., Look M.P., de Weerd V., Boersma A.W., Klijn J.G., Wiemer E.A., Martens J.W. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13021-13026.
27. Gabriely G., Wurdinger T., Kesari S., Esau C.C., Burchard J., Linsley P.S., Krichevsky A.M. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 2008, 28:5369-5380.
28. Garofalo M., Di Leva G., Romano G., Nuovo G., Suh S.S., Ngankeu A., Taccioli C., Pichiorri F., Alder H., Secchiero P., Gasparini P., Gonelli A., Costinean S., Acunzo M., Condorelli G., Croce C.M. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 2009, 16:498-509.
29. Gauthier B.R., Wollheim C.B. MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat. Med. 2006, 12:36-38.
30. Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 1997, 74:111-122.
31. Gottardo F., Liu C.G., Ferracin M., Calin G.A., Fassan M., Bassi P., Sevignani C., Byrne D., Negrini M., Pagano F., Gomella L.G., Croce C.M., Baffa R. Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 2007, 25:387-392.
32. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
33. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36:D154-D158.
34. Gunthert U., Hofmann M., Rudy W., Reber S., Zoller M., Haussmann I., Matzku S., Wenzel A., Ponta H., Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991, 65:13-24.
35. Guttilla I.K., White B.A. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J. Biol. Chem. 2009, 284:23204-23216.
36. Hatfield S.D., Shcherbata H.R., Fischer K.A., Nakahara K., Carthew R.W., Ruohola-Baker H. Stem cell division is regulated by the microRNA pathway. Nature 2005, 435:974-978.
37. Henderson D.J., Copp A.J. Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. Circ. Res. 1998, 83:523-532.
38. Hernandez-Barrantes S., Bernardo M., Toth M., Fridman R. Regulation of membrane type-matrix metalloproteinases. Semin. Cancer Biol. 2002, 12:131-138.
39. Houbaviy H.B., Dennis L., Jaenisch R., Sharp P.A. Characterization of a highly variable eutherian microRNA gene. RNA 2005, 11:1245-1257.
40. Huang Q., Gumireddy K., Schrier M., le Sage C., Nagel R., Nair S., Egan D.A., Li A., Huang G., Klein-Szanto A.J., Gimotty P.A., Katsaros D., Coukos G., Zhang L., Pure E., Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol. 2008, 10:202-210.
41. Huang T.H., Zhu M.J., Li X.Y., Zhao S.H. Discovery of porcine microRNAs and profiling from skeletal muscle tissues during development. PLoS One 2008, 3:e3225.
42. Huang X.H., Chen J.S., Wang Q., Chen X.L., Wen L., Chen L.Z., Bi J., Zhang L.J., Su Q., Zeng W.T. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J. Pathol. 2011, 225:463-472.
43. Hunt S., Jones A.V., Hinsley E.E., Whawell S.A., Lambert D.W. MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Lett. 2011, 585:187-192.
44. Hwang-Verslues W.W., Chang P.H., Wei P.C., Yang C.Y., Huang C.K., Kuo W.H., Shew J.Y., Chang K.J., Lee E.Y., Lee W.H. miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1. Oncogene 2011, 30:2463-2474.
45. Iida N., Bourguignon L.Y. New CD44 splice variants associated with human breast cancers. J. Cell. Physiol. 1995, 162:127-133.
46. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Menard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M., Croce C.M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
47. Jeyapalan Z., Deng Z., Shatseva T., Fang L., He C., Yang B.B. Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res. 2011, 39:3026-3041.
48. Ji J., Zhao L., Budhu A., Forgues M., Jia H.L., Qin L.X., Ye Q.H., Yu J., Shi X., Tang Z.Y., Wang X.W. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J. Hepatol. 2010, 52:690-697.
49. Johansson N., Airola K., Grenman R., Kariniemi A.L., Saarialho-Kere U., Kahari V.M. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am. J. Pathol. 1997, 151:499-508.
50. Johnston R.J., Hobert O. A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans. Nature 2003, 426:845-849.
51. Kahai S., Lee S.C., Lee D.Y., Yang J., Li M., Wang C.H., Jiang Z., Zhang Y., Peng C., Yang B.B. MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS One 2009, 4:e7535.
52. Kato M., Zhang J., Wang M., Lanting L., Yuan H., Rossi J.J., Natarajan R. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3432-3437.
53. Kato M., Putta S., Wang M., Yuan H., Lanting L., Nair I., Gunn A., Nakagawa Y., Shimano H., Todorov I., Rossi J.J., Natarajan R. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 2009, 11:881-889.
54. Kim D., Song J., Jin E.J. MicroRNA-221 regulates chondrogenic differentiation through promoting proteosomal degradation of slug by targeting Mdm2. J. Biol. Chem. 2010, 285:26900-26907.
55. Kim D., Song J., Kim S., Park H.M., Chun C.H., Sonn J., Jin E.J. MicroRNA-34a modulates cytoskeletal dynamics through regulating RhoA/Rac1 cross-talk in chondroblasts. J. Biol. Chem. 2012, 287:12501-12509.
56. Kinsella M.G., Bressler S.L., Wight T.N. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit. Rev. Eukaryot. Gene Expr. 2004, 14:203-234.
57. Lambert E., Dasse E., Haye B., Petitfrere E. TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 2004, 49:187-198.
58. Latronico M.V., Catalucci D., Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ. Res. 2007, 101:1225-1236.
59. Lee D.Y., Deng Z., Wang C., Yang B.B. MicroRNA mir-378 promotes cell survival, tumor growth, and angiogenesis by targeting Sufu and Fus-1 expression. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20350-20355.
60. Lee D.Y., Shatseva T., Jeyapalan Z., Du W.W., Deng Z., Yang B.B. A 3'-untranslated region (3'UTR) induces organ adhesion by regulating miR-199a functions. PLoS One 2009, 4:e4527.
61. Lee D.Y., Jeyapalan Z., Fang L., Yang J., Zhang Y., Yee A.Y., Li M., Du W.W., Shatseva T., Yang B.B. Expression of versican 3'-untranslated region modulates endogenous microRNA functions. PLoS One 2010, 5:e13599.
62. Lee S.C., Fang L., Wang C.H., Kahai S., Deng Z., Yang B.B. A non-coding transcript of nephronectin promotes osteoblast differentiation by modulating microRNA functions. FEBS Lett. 2011, 585:2610-2616.
63. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
64. Li Y., Song Y.H., Li F., Yang T., Lu Y.W., Geng Y.J. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem. Biophys. Res. Commun. 2009, 381:81-83.
65. Li G., Luna C., Qiu J., Epstein D.L., Gonzalez P. Targeting of integrin beta1 and kinesin 2alpha by microRNA 183. J. Biol. Chem. 2010, 285:5461-5471.
66. Li C., Nguyen H.T., Zhuang Y., Lin Y., Flemington E.K., Guo W., Guenther J., Burow M.E., Morris G.F., Sullivan D., Shan B. Post-transcriptional up-regulation of miR-21 by type I collagen. Mol. Carcinog. 2011, 50:563-570.
67. Li X., Gibson G., Kim J.S., Kroin J., Xu S., van Wijnen A.J., Im H.J. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene 2011, 480:34-41.
68. Li Y., Zhang H., Chen Y. MicroRNA-mediated positive feedback loop and optimized bistable switch in a cancer network Involving miR-17-92. PLoS One 2011, 6:e26302.
69. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
70. Lin S.L., Chiang A., Chang D., Ying S.Y. Loss of mir-146a function in hormone-refractory prostate cancer. RNA 2008, 14:417-424.
71. Lin E.A., Kong L., Bai X.H., Luan Y., Liu C.J. miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J. Biol. Chem. 2009, 284:11326-11335.
72. Liu J., Valencia-Sanchez M.A., Hannon G.J., Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell Biol. 2005, 7:719-723.
73. Liu H., Cao Y.D., Ye W.X., Sun Y.Y. Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDA-MB-231 cells. Tumori 2010, 96:751-755.
74. Liu H., Chen S.E., Jin B., Carson J.A., Niu A., Durham W., Lai J.Y., Li Y.P. TIMP3: a physiological regulator of adult myogenesis. J. Cell Sci. 2010, 123:2914-2921.
75. Liu C., Kelnar K., Liu B., Chen X., Calhoun-Davis T., Li H., Patrawala L., Yan H., Jeter C., Honorio S., Wiggins J.F., Bader A.G., Fagin R., Brown D., Tang D.G. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 2011, 17:211-215.
76. Lowery A.J., Miller N., Devaney A., McNeill R.E., Davoren P.A., Lemetre C., Benes V., Schmidt S., Blake J., Ball G., Kerin M.J. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res. 2009, 11:R27.
77. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., Teruya-Feldstein J., Reinhardt F., Onder T.T., Valastyan S., Westermann F., Speleman F., Vandesompele J., Weinberg R.A. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 2010, 12:247-256.
78. Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front. Biosci. 2006, 11:1696-1701.
79. Marhaba R., Zoller M. CD44 in cancer progression: adhesion, migration and growth regulation. J. Mol. Histol. 2004, 35:211-231.
80. Merline R., Moreth K., Beckmann J., Nastase M.V., Zeng-Brouwers J., Tralhao J.G., Lemarchand P., Pfeilschifter J., Schaefer R.M., Iozzo R.V., Schaefer L. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and microRNA-21. Sci. Signal. 2011, 4:ra75.
81. Mertens-Talcott S.U., Chintharlapalli S., Li X., Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 2007, 67:11001-11011.
82. Miyaki S., Nakasa T., Otsuki S., Grogan S.P., Higashiyama R., Inoue A., Kato Y., Sato T., Lotz M.K., Asahara H. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 2009, 60:2723-2730.
83. Morton S.U., Scherz P.J., Cordes K.R., Ivey K.N., Stainier D.Y., Srivastava D. microRNA-138 modulates cardiac patterning during embryonic development. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17830-17835.
84. Murphy G., Knauper V., Lee M.H., Amour A., Worley J.R., Hutton M., Atkinson S., Rapti M., Williamson R. Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. Biochem. Soc. Symp. 2003, 65-80.
85. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274:21491-21494.
86. Nielsen B.S., Rank F., Lopez J.M., Balbin M., Vizoso F., Lund L.R., Dano K., Lopez-Otin C. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res. 2001, 61:7091-7100.
87. Olayioye M.A. Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members. Breast Cancer Res. 2001, 3:385-389.
88. Osaki M., Takeshita F., Sugimoto Y., Kosaka N., Yamamoto Y., Yoshioka Y., Kobayashi E., Yamada T., Kawai A., Inoue T., Ito H., Oshimura M., Ochiya T. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol. Ther. 2011, 19:1123-1130.
89. Pan Q., Luo X., Chegini N. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Mol. Hum. Reprod. 2010, 16:215-227.
90. Polette M., Nawrocki-Raby B., Gilles C., Clavel C., Birembaut P. Tumour invasion and matrix metalloproteinases. Crit. Rev. Oncol. Hematol. 2004, 49:179-186.
91. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., Rainaldi G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108:3068-3071.
92. Pramanik D., Campbell N.R., Karikari C., Chivukula R., Kent O.A., Mendell J.T., Maitra A. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 2011, 10:1470-1480.
93. Ricciardelli C., Sakko A.J., Ween M.P., Russell D.L., Horsfall D.J. The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev. 2009, 28:233-245.
94. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004, 14:1902-1910.
95. Ropponen K.M., Eskelinen M.J., Lipponen P.K., Alhava E., Kosma V.M. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand. J. Gastroenterol. 1998, 33:301-309.
96. Rutnam Z.J., Yang B.B. The non-coding 3'UTR of CD44 induces metastasis by regulating extracellular matrix functions. J. Cell Sci. 2012, 125:2075-2085.
97. Ruvkun G. Clarifications on miRNA and cancer. Science 2006, 311:36-37.
98. Saini H.K., Griffiths-Jones S., Enright A.J. Genomic analysis of human microRNA transcripts. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17719-17724.
99. Scott G.K., Goga A., Bhaumik D., Berger C.E., Sullivan C.S., Benz C.C. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 2007, 282:1479-1486.
100. Sekiya Y., Ogawa T., Yoshizato K., Ikeda K., Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem. Biophys. Res. Commun. 2011, 412:74-79.
101. Selaru F.M., Olaru A.V., Kan T., David S., Cheng Y., Mori Y., Yang J., Paun B., Jin Z., Agarwal R., Hamilton J.P., Abraham J., Georgiades C., Alvarez H., Vivekanandan P., Yu W., Maitra A., Torbenson M., Thuluvath P.J., Gores G.J., LaRusso N.F., Hruban R., Meltzer S.J. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 2009, 49:1595-1601.
102. Sengupta S., den Boon J.A., Chen I.H., Newton M.A., Stanhope S.A., Cheng Y.J., Chen C.J., Hildesheim A., Sugden B., Ahlquist P. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5874-5878.
103. Shan S.W., Lee D.Y., Deng Z., Shatseva T., Jeyapalan Z., Du W.W., Zhang Y., Xuan J.W., Yee S.P., Siragam V., Yang B.B. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat. Cell Biol. 2009, 11:1031-1038.
104. Shi X.B., Tepper C.G., deVere White R.W. Cancerous miRNAs and their regulation. Cell Cycle 2008, 7:1529-1538.
105. Shi W., Gerster K., Alajez N.M., Tsang J., Waldron L., Pintilie M., Hui A.B., Sykes J., P'ng C., Miller N., McCready D., Fyles A., Liu F.F. MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res. 2011, 71:2926-2937.
106. Song L., Huang Q., Chen K., Liu L., Lin C., Dai T., Yu C., Wu Z., Li J. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-beta. Biochem. Biophys. Res. Commun. 2010, 402:135-140.
107. Song J., Kim D., Jin E.J. MicroRNA-488 suppresses cell migration through modulation of the focal adhesion activity during chondrogenic differentiation of chick limb mesenchymal cells. Cell Biol. Int. 2011, 35:179-185.
108. Stanczyk J., Pedrioli D.M., Brentano F., Sanchez-Pernaute O., Kolling C., Gay R.E., Detmar M., Gay S., Kyburz D. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008, 58:1001-1009.
109. Stanczyk J., Ospelt C., Karouzakis E., Filer A., Raza K., Kolling C., Gay R., Buckley C.D., Tak P.P., Gay S., Kyburz D. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum. 2011, 63:373-381.
110. Steele R., Mott J.L., Ray R.B. MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells. Genes Cancer 2010, 1:381-387.
111. Sun L., Yan W., Wang Y., Sun G., Luo H., Zhang J., Wang X., You Y., Yang Z., Liu N. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res. 2011, 1389:9-18.
112. Surgucheva I., Chidambaram K., Willoughby D.A., Surguchov A. Matrix metalloproteinase 9 expression: new regulatory elements. J. Ocul. Biol. Dis. Inform. 2010, 3:41-52.
113. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 1993, 5:806-811.
114. Tuddenham L., Wheeler G., Ntounia-Fousara S., Waters J., Hajihosseini M.K., Clark I., Dalmay T. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 2006, 580:4214-4217.
115. Turner C.E., Burridge K. Transmembrane molecular assemblies in cell-extracellular matrix interactions. Curr. Opin. Cell Biol. 1991, 3:849-853.
116. Ucar A., Vafaizadeh V., Jarry H., Fiedler J., Klemmt P.A., Thum T., Groner B., Chowdhury K. miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat. Genet. 2010, 42:1101-1108.
117. Valastyan S., Reinhardt F., Benaich N., Calogrias D., Szasz A.M., Wang Z.C., Brock J.E., Richardson A.L., Weinberg R.A. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.
118. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18255-18260.
119. Wang C.H., Lee D.Y., Deng Z., Jeyapalan Z., Lee S.C., Kahai S., Lu W.Y., Zhang Y., Yang B.B. MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS One 2008, 3:e2420.
120. Wang Q., Wang Y., Minto A.W., Wang J., Shi Q., Li X., Quigg R.J. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 2008, 22:4126-4135.
121. Wang G., Mao W., Zheng S., Ye J. Epidermal growth factor receptor-regulated miR-125a-5p-a metastatic inhibitor of lung cancer. FEBS J. 2009, 276:5571-5578.
122. Wang B., Herman-Edelstein M., Koh P., Burns W., Jandeleit-Dahm K., Watson A., Saleem M., Goodall G.J., Twigg S.M., Cooper M.E., Kantharidis P. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 2010, 59:1794-1802.
123. Wang B., Hsu S.H., Majumder S., Kutay H., Huang W., Jacob S.T., Ghoshal K. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 2010, 29:1787-1797.
124. Wang X., Hu G., Zhou J. Repression of versican expression by microRNA-143. J. Biol. Chem. 2010, 285:23241-23250.
125. Watabe M., Nagafuchi A., Tsukita S., Takeichi M. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J. Cell Biol. 1994, 127:247-256.
126. Weiss G.J., Bemis L.T., Nakajima E., Sugita M., Birks D.K., Robinson W.A., Varella-Garcia M., Bunn P.A., Haney J., Helfrich B.A., Kato H., Hirsch F.R., Franklin W.A. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann. Oncol. 2008, 19:1053-1059.
127. Wickramasinghe N.S., Manavalan T.T., Dougherty S.M., Riggs K.A., Li Y., Klinge C.M. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res. 2009, 37:2584-2595.
128. Wielenga V.J., Heider K.H., Offerhaus G.J., Adolf G.R., van den Berg F.M., Ponta H., Herrlich P., Pals S.T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 1993, 53:4754-4756.
129. Wight T.N. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 2002, 14:617-623.
130. Wight T.N., Merrilees M.J. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 2004, 94:1158-1167.
131. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991, 5:2145-2154.
132. Wu Y., Wu J., Lee D.Y., Yee A., Cao L., Zhang Y., Kiani C., Yang B.B. Versican protects cells from oxidative stress-induced apoptosis. Matrix Biol. 2005, 24:3-13.
133. Wu F., Zikusoka M., Trindade A., Dassopoulos T., Harris M.L., Bayless T.M., Brant S.R., Chakravarti S., Kwon J.H. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008, 135(1624-1635):e1624.
134. Wu Z.S., Wu Q., Wang C.Q., Wang X.N., Huang J., Zhao J.J., Mao S.S., Zhang G.H., Xu X.C., Zhang N. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer 2011, 117:2842-2852.
135. Xia H., Qi Y., Ng S.S., Chen X., Li D., Chen S., Ge R., Jiang S., Li G., Chen Y., He M.L., Kung H.F., Lai L., Lin M.C. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res. 2009, 1269:158-165.
136. Xiang Y.Y., Dong H., Wan Y., Li J., Yee A., Yang B.B., Lu W.Y. Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor. J. Biol. Chem. 2006, 281:19358-19368.
137. Yan W., Zhang W., Sun L., Liu Y., You G., Wang Y., Kang C., You Y., Jiang T. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme. Brain Res. 2011, 1411:108-115.
138. Yang B., Guo H., Zhang Y., Chen L., Ying D., Dong S. MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PLoS One 2011, 6:e21679.
139. Yang W., Lee D.Y., Ben-David Y. The roles of microRNAs in tumorigenesis and angiogenesis. Int. J. Physiol. Pathophysiol. Pharmacol. 2011, 3:140-155.
140. Yao L.Y., Moody C., Schonherr E., Wight T.N., Sandell L.J. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol. 1994, 14:213-225.
141. Zhang X., Liu S., Hu T., He Y., Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009, 50:490-499.
142. Zitka O., Kukacka J., Krizkova S., Huska D., Adam V., Masarik M., Prusa R., Kizek R. Matrix metalloproteinases. Curr. Med. Chem. 2010, 17:3751-3768.